1NEWS, The 2022 Asian Badminton Championships to be held in Manila, Philippines, are just a few days away. China is still king so far while Indonesia is still looking for ways to create a balance of power.
The Badminton Asia Championship is one of the three main continental tournaments in Asia, the other two being the Badminton Asia Team Championship (BATC) and the Badminton Asia Mixed Team Championship (BAMTC).
BAC was first held in Kuala Lumpur, Malaysia in 1962 and has been held annually since 1991 to crown the best badminton player in the Asian continent.
After being canceled twice in the year since 2020 due to the COVID-19 pandemic, BAC will be held again this year at the Muntinlupa Sports Complex, Manila, Philippines, on April 26 – May 1, 2022.
This will be the 39th edition of the tournament. As for Manila, this is the third time they have hosted BAC after previously they did so in 1961 and 2001.
Prior to the two-year gap, the tournament was held in Wuhan, China, for five consecutive years from 2015 to 2019.
In this event, the top players in Asia will compete for the title of best player in Asia and earn 12,000 points for their BWF World Rankings.
Each country can only send a maximum of 4 eligible representatives per category.
Throughout the history of the Badminton Asia Championships, China has held the most medals with a total of 202 medals for nearly two decades (1994-2019).
Launching from the Badminton Indonesia account on Instagram, China has so far collected 62 gold, 61 silver and 79 bronze medals.
BAC’s Most Medals Earned
In the last edition, China and Japan became the countries that dominated the title acquisition. Japan won three titles, and two titles were won by China.
The hosts of the tournament won 2 titles in the women’s doubles sector, represented by Chen Qing Chen/Jia Yi Fan and their mixed doubles Wang Yi Lyu/Huang Dong Ping.
Far behind China, the second most BAC medals were placed by Korea. The country of Ginseng has just collected 76 medals consisting of 25 gold, 15 silver and 36 bronze.
Then what about Indonesia? The country, which is also one of the superpowers in the tepok bulu sport, was in third place in BAC’s medal tally.
The Red and White Team, for almost two decades, has only collected a total of 102 medals consisting of 21 gold, 24 silver and 57 bronze.
It is known that Indonesia failed to win the title in the tournament in the 2019 edition. It was noted that the representative of the country only won the runner-up title, aka the second winner.
Kevin Sanjaya Sukamuljo/Marcus Fernaldi Gideon’s men’s doubles were surprisingly beaten by Japanese representatives Hiroyuki Endo/Yuta Watanabe with a score of 18-21, 3-21.
With Indonesia currently experiencing a resurgence in the men’s singles and doubles sectors, it is not impossible that they will be one step closer to Korea in the number of gold medals.
This can be seen from the achievements of Indonesian representatives in the men’s sector in the last few months, namely winning several titles on the European Tour.
Starting from the success of the men’s doubles, Bagas Maulana/Muhammad Shohibul Fikri won their first All England title.
Followed by the success of Fajar Alfian/Muhammad Rian Ardianto and Jonatan Christie who won the title at the 2022 Swiss Open.
China will be lame without Chen Yu Fei at BAC 2022
Without the badminton queen ranked 3 in the world, Chen Yu Fei, China will appear limp even though it is still fierce in the 2022 Badminton Asia Championships.
The Tokyo 2020 Olympic champion also has fond memories of winning silver and bronze medals at the 2018-2019 edition of the Badminton Asia Championships.
Unfortunately, in the release of the Asian Badminton Confederation, there are no names of Chen Yu Fei or Shi Yuqi in the China squad for the 2022 Badminton Asia Championships.
Understood. As far as her performances go from the start of 2022, China’s singles best has yet to achieve its best results.
It is possible that Chen Yu Fei will withdraw from the upcoming 2022 Badminton Asia Championships. Local Chinese media, Sohu, also confirmed this.